Camlin Fine Sciences Ltd

CAMLINFINE

Company Profile

  • Business description

    Camlin Fine Sciences Ltd is engaged in the research, development, manufacturing, and marketing of specialty chemicals, ingredients, and additive blends. Its broad product portfolio includes Shelf-Life Solutions, Aroma Ingredients, Performance Chemicals, and Health & Wellness. The Company operates through one reporting business segment, Specialty Chemicals. Its products include Hydroquinone (HQ), Catechol (CAT), Monomethyl Ether of HQ (MEHQ), Tert Butylcatechol (TBC), Guaiacol, Veratrole, Xtendra, Nasure, Ezential, adorr, Vitafor, Dinamic, and Biosus. It serves Food & Beverages, Petfood and Rendering, Animal Nutrition, Petrochemicals, Nutrition & Health, Biofuel, Flavours & Fragrances, and other industries, and generates maximum revenue from the domestic market.

  • Contact

    CST Road, Kalina
    Floor 2 to 5, In GS Point
    Santacruz East
    MumbaiMH400 098
    IND

    T: +91 2267001000

    https://www.camlinfs.com

  • Sector

    Basic Materials

    Stock type

    Cyclical

  • Industry

    Specialty Chemicals

    Fiscal Year End

    31 March 2027

    Employees

    1,557

Stocks News & Analysis

stocks

Weight loss drugs not an existential threat to undervalued ASX share

A durable growth story despite GLP-1 headwinds.
stocks

Tesla: valuation is key consideration in merger talks with SpaceX

We see regulatory risk from both the US and Chinese governments.
stocks

ASX data center shares remain cheap after downgrade

Near-term pain, long-term potential.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,938.8012.200.14%
CAC 407,847.3264.500.83%
DAX 4025,410.84229.190.91%
Dow JONES (US)52,361.58146.420.28%
FTSE 10010,767.3376.970.72%
HKSE23,172.8538.96-0.17%
NASDAQ26,169.38214.040.82%
Nikkei 22563,381.291,191.641.92%
NZX 50 Index13,631.88102.05-0.74%
S&P 5007,676.7753.090.70%
S&P/ASX 2008,818.909.000.10%
SSE Composite Index3,695.042.48-0.07%

Market Movers